Ganfeng Lithium Co., Limited (1772.HK)
HKD 18.3
(-0.44%)
HKD 18.3
(-0.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.21 Billion CNY | -77.08% |
| 2022 | 22.76 Billion CNY | 298.03% |
| 2021 | 5.71 Billion CNY | 403.88% |
| 2020 | 1.13 Billion CNY | -2.71% |
| 2019 | 1.16 Billion CNY | -14.88% |
| 2018 | 1.37 Billion CNY | -21.89% |
| 2017 | 1.75 Billion CNY | 204.66% |
| 2016 | 575.94 Million CNY | 344.73% |
| 2015 | 129.5 Million CNY | 40.55% |
| 2014 | 92.14 Million CNY | 18.63% |
| 2013 | 77.67 Million CNY | 10.73% |
| 2012 | 70.14 Million CNY | 23.92% |
| 2011 | 56.6 Million CNY | 19.65% |
| 2010 | 47.31 Million CNY | 21.57% |
| 2009 | 38.91 Million CNY | -10.26% |
| 2008 | 43.36 Million CNY | 9.97% |
| 2007 | 39.43 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -499.74 Million CNY | 53.41% |
| 2024 Q2 | -506.56 Million CNY | -1.36% |
| 2023 Q4 | -1.07 Billion CNY | -1055.71% |
| 2023 FY | 5.21 Billion CNY | -77.08% |
| 2023 Q1 | 2.35 Billion CNY | -57.62% |
| 2023 Q2 | 3.82 Billion CNY | 62.48% |
| 2023 Q3 | 112.23 Million CNY | -97.07% |
| 2022 Q4 | 5.55 Billion CNY | -37.0% |
| 2022 FY | 22.76 Billion CNY | 298.03% |
| 2022 Q1 | 4 Billion CNY | 38.18% |
| 2022 Q2 | 4.39 Billion CNY | 9.72% |
| 2022 Q3 | 8.81 Billion CNY | 100.8% |
| 2021 Q3 | 1.18 Billion CNY | 6.88% |
| 2021 Q4 | 2.89 Billion CNY | 144.73% |
| 2021 FY | 5.71 Billion CNY | 403.88% |
| 2021 Q1 | 532.64 Million CNY | -26.22% |
| 2021 Q2 | 1.1 Billion CNY | 107.85% |
| 2020 Q3 | 221.25 Million CNY | 31.57% |
| 2020 Q2 | 168.16 Million CNY | 613.28% |
| 2020 Q1 | 23.57 Million CNY | -52.88% |
| 2020 FY | 1.13 Billion CNY | -2.71% |
| 2020 Q4 | 721.96 Million CNY | 226.3% |
| 2019 Q1 | 299.59 Million CNY | 189.84% |
| 2019 Q4 | 50.03 Million CNY | 28.13% |
| 2019 Q3 | 39.05 Million CNY | -54.92% |
| 2019 FY | 1.16 Billion CNY | -14.88% |
| 2019 Q2 | 86.62 Million CNY | -71.09% |
| 2018 Q1 | 422.02 Million CNY | -31.38% |
| 2018 Q4 | 103.36 Million CNY | -67.01% |
| 2018 FY | 1.37 Billion CNY | -21.89% |
| 2018 Q3 | 313.37 Million CNY | -41.07% |
| 2018 Q2 | 531.74 Million CNY | 26.0% |
| 2017 Q1 | 158.18 Million CNY | 605.75% |
| 2017 FY | 1.75 Billion CNY | 204.66% |
| 2017 Q4 | 614.99 Million CNY | 32.03% |
| 2017 Q3 | 465.78 Million CNY | -9.68% |
| 2017 Q2 | 515.71 Million CNY | 226.01% |
| 2016 FY | 575.94 Million CNY | 344.73% |
| 2016 Q4 | -31.27 Million CNY | -113.21% |
| 2016 Q3 | 236.83 Million CNY | 6.59% |
| 2016 Q1 | 148.18 Million CNY | 272.88% |
| 2016 Q2 | 222.19 Million CNY | 49.95% |
| 2015 Q4 | 39.73 Million CNY | 19.75% |
| 2015 Q1 | 28.15 Million CNY | 1.4% |
| 2015 Q2 | 28.42 Million CNY | 0.98% |
| 2015 Q3 | 33.18 Million CNY | 16.74% |
| 2015 FY | 129.5 Million CNY | 40.55% |
| 2014 Q1 | 23.49 Million CNY | -2.49% |
| 2014 Q4 | 27.76 Million CNY | 31.3% |
| 2014 Q3 | 21.14 Million CNY | 7.09% |
| 2014 Q2 | 19.74 Million CNY | -15.94% |
| 2014 FY | 92.14 Million CNY | 18.63% |
| 2013 Q3 | 17.58 Million CNY | -1.21% |
| 2013 FY | 77.67 Million CNY | 10.73% |
| 2013 Q1 | 18.2 Million CNY | 20.48% |
| 2013 Q2 | 17.79 Million CNY | -2.21% |
| 2013 Q4 | 24.09 Million CNY | 37.01% |
| 2012 Q3 | 20.9 Million CNY | 39.9% |
| 2012 FY | 70.14 Million CNY | 23.92% |
| 2012 Q1 | 19.19 Million CNY | 65.02% |
| 2012 Q2 | 14.94 Million CNY | -22.16% |
| 2012 Q4 | 15.1 Million CNY | -27.72% |
| 2011 Q2 | 13.53 Million CNY | -8.23% |
| 2011 FY | 56.6 Million CNY | 19.65% |
| 2011 Q4 | 11.63 Million CNY | -30.34% |
| 2011 Q3 | 16.69 Million CNY | 23.4% |
| 2011 Q1 | 14.74 Million CNY | 27.85% |
| 2010 Q1 | 13.3 Million CNY | -12.48% |
| 2010 FY | 47.31 Million CNY | 21.57% |
| 2010 Q4 | 11.53 Million CNY | 16.09% |
| 2010 Q3 | 9.93 Million CNY | -20.77% |
| 2010 Q2 | 12.53 Million CNY | -5.74% |
| 2009 Q3 | 11.9 Million CNY | 0.0% |
| 2009 Q4 | 15.19 Million CNY | 27.72% |
| 2009 FY | 38.91 Million CNY | -10.26% |
| 2008 FY | 43.36 Million CNY | 9.97% |
| 2007 FY | 39.43 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 14.89 Million HKD | -34938.5% |
| Lee & Man Chemical Company Limited | 473.28 Million HKD | -1002.562% |